drugset / Trial / NCT01793259
Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA)
RandomizedCrossoverOpen-labelTreatment
Summary
The primary objective of this study is to assess the number of patients preferring the methotrexate pre-filled pen to the methotrexate pre-filled syringe after 6 weeks of treatment based on a questionnaire
Timeline
- Start
- 2012-07
- Primary completion
- 2013-04
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methotrexate | Small molecule | 15 mg | Subcutaneous |
| Subject | Methotrexate | Small molecule | 17.5 mg | Subcutaneous |
| Subject | Methotrexate | Small molecule | 20 mg | Subcutaneous |